Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...